Asia Pacific Prostate Cancer Diagnostic and Therapeutic Market to Witness Growth Acceleration by 2025
Asia Pacific prostate cancer market is expected to grow at a CAGR of 7.9% during the forecast period. As per the World Health Organization, Asia Pacific is the second largest region in terms of new cases of prostate cancer globally. In 2018, around 321,000 new cases of prostate cancer were registered in the region. China has the highest incidence in the region followed by Japan however Australia has a very high incidence rate of prostate cancer. The highest rates of prostate cancer are reported in Australia and New Zealand presumably due to prostate-specific antigen (PSA) screening is done widely in these regions. In Asia Pacific, prostate cancer incidence has been reported to vary from country to country.
(Get 25% Discount on Buying this Report)
To Request a Sample of our Report on Asia
Pacific Prostate Cancer Diagnostic and Therapeutic Market: https://www.omrglobal.com/request-sample/asia-pacific-prostate-cancer-diagnostic-therapeutic-market
There has been a consistent increase
in the age-standardized incidence rates of prostate cancer in Asian countries
over the last few decades, particularly in Singapore, China, Malaysia, and
Japan. This has been reported to be due to changes in diet and other lifestyle
factors in these countries. Moreover, the adoption of innovative technologies
for the diagnosis of prostate cancer such as biomarkers and the adoption of
personalized medicine for treatment is expected to provide a significant opportunity
to the market.
A
full Report of Asia Pacific Prostate Cancer Diagnostic and Therapeutic Market is
Available @ https://www.omrglobal.com/industry-reports/asia-pacific-prostate-cancer-diagnostic-therapeutic-market
Asia Pacific Prostate Cancer Market Segmentation
By Diagnostic Techniques
·
Prostate-Specific Antigen Test (PSA)
·
Digital Rectal Examination
·
Prostate Biopsy
·
Imaging Techniques
By Therapeutics
·
Hormonal Therapy
·
Chemotherapy
·
Immunotherapy
·
Radiation Therapy
·
Targeted Therapy
·
Surgery
Regional Analysis
·
China
·
Japan
·
India
Rest of Asia Pacific
Company
Profiles
·
Abbott Laboratories
·
AbbVie Products, LLC
·
Amgen Inc.
·
AstraZeneca PLC
·
Bayer AG
·
Bristol-Myers Squibb Co.
·
Endo Pharmaceuticals Inc.
·
Ferring Pharmaceuticals Inc.
·
GlaxoSmithKline PLC
·
Johnson & Johnson
·
Pfizer Inc.
·
Siemens Healthcare AG
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment